Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

BACKGROUND: Chloroquine and hydroxychloroquine have been found to be efficient on SARS-CoV-2, and reported to be efficient in Chinese COV-19 patients. We evaluate the effect of hydroxychloroquine on respiratory viral loads. PATIENTS AND METHODS: French Confirmed COVID-19 patients were included in a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int J Antimicrob Agents
Autores principales: Gautret, Philippe, Lagier, Jean-Christophe, Parola, Philippe, Hoang, Van Thuan, Meddeb, Line, Mailhe, Morgane, Doudier, Barbara, Courjon, Johan, Giordanengo, Valérie, Vieira, Vera Esteves, Tissot Dupont, Hervé, Honoré, Stéphane, Colson, Philippe, Chabrière, Eric, La Scola, Bernard, Rolain, Jean-Marc, Brouqui, Philippe, Raoult, Didier
Formato: Artigo
Lenguaje:Inglês
Publicado: Published by Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7102549/
https://ncbi.nlm.nih.gov/pubmed/32205204
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijantimicag.2020.105949
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares